Corbevax by September end in India, said sources on Monday. Sources told ANI that the company has started its phase 3 clinical trials.
Biological E's COVID-19 vaccine Corbevax has been booked by the government before preclinical stage phase 3 studies. In the latest written reply, Union Minister of State for Health, Dr Bharati Pravin Pawar said that the Government of India has also provided financial assistance to domestic vaccine manufacturer Biological E which is currently in advance phase 3 clinical trials for 'at-risk manufacturing' of the COVID-19 vaccine.
Biological E is expected to apply for an Emergency use License (EUL) by August end and will be supplying 300 million doses to the Government of India by December 2021.
Read more on livemint.com